New York medical center to launch Medicaid coverage for schizophrenia medication

FourFourThree – One of New York’s newest hospitals will begin offering Medicaid coverage of the medications used in patients with schizophrenia.

Aurora Healthcare’s new facility in the Bronx will open July 1 and become part of a pilot program to provide coverage for two of its medication classes, including lithium, which is prescribed for patients with bipolar disorder.

The company says that the medication is among the few medications approved by the Food and Drug Administration for the condition.

The medication is often used as a treatment for attention deficit disorder and attention deficit hyperactivity disorder.

A patient with schizophrenia will receive $50 for a two-week supply of lithium.

Patients can buy two doses of lithium for $200.

The first dose will cost $25, and the second will cost a total of $100.